The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) strives to create a cancer-free world by integrating research with excellence in education and patient-centered care, a strategy that leads to better methods of cancer prevention, detection and treatment. The OSUCCC – James is one of 54 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and maintains the NCI’s highest rating of “exceptional.” It is one of only a few centers funded by the NCI to conduct phase I, II and III clinical trials on novel anticancer drugs provided by the NCI. As the cancer program’s 356-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet® designation, the highest honor an organization can receive for quality patient care and professional nursing practice. With 21 floors and over 1.1 million square feet, The James is a transformational facility that fosters integration of cancer research and clinical care.
To learn more, visit https://cancer.osu.edu/.